CEO Ivor Elrifi Adds Another $321K Stake, Bringing Total Holdings to 4.79M Shares
TLSA sits 17% above its 52-week low of $0.866 on elevated volume (3.2× avg).
Summary
CEO Ivor Elrifi purchased an additional 321,423 shares at $1.00, a $321,423 investment, bringing his total holdings to 4.79 million shares. This follows a $667,000 purchase two days ago, marking a clear accumulation pattern.
Key Events · Ownership and Investor Activity · TLSA
-
CEO Purchases Additional 321,423 Shares
CEO Ivor Elrifi bought 321,423 shares at $1.00 per share, a $321,423 investment, increasing his total holdings to 4,793,684 common shares.
-
Back-to-Back Insider Buying
This purchase follows a $667,000 buy on August 4, 2026, bringing the CEO's total two-day investment to nearly $1 million.
-
Strong Conviction Signal
The CEO's repeated open-market purchases at $1.00 suggest high confidence in the company's intranasal foralumab program, with Phase 2 data expected.
Analysis · TLSA · Life Sciences
Just two days after a $667,000 purchase, CEO Ivor Elrifi bought another 321,423 shares at $1.00, investing an additional $321,423. His total holdings now stand at 4.79 million shares, underscoring a pattern of aggressive insider accumulation. The back-to-back buys signal strong conviction in the company's intranasal foralumab program, especially with Phase 2 data readouts on the horizon.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TLSA was trading at $1.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $127M. The 52-week trading range was $0.87 to $2.53. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.